Asia Pacific Enteral Medical Nutrition Market

The enteral medical nutrition market in Asia Pacific is expected to grow from US$ 1,057.41million in 2022 to US$ 1,641.69 million by 2028. It is estimated to grow at a CAGR of 5.9% from 2022 to 2028. 

Use of Next Generation Technology for Proper Enteral Nutrition Feeding 

In enteral feeding, it is important to calculate patient’s daily and cumulative energy balance, as it helps doctor plan the feeding routing according to the need of patient and decrease the morbidity and mortality risk among the patients. It is also essential to maintain the nutrient supply after discharge. There is no proper technology or equipment available for calculating the patient’s daily and cumulative energy balance. Researchers are now focusing on the use of artificial intelligence (AI) and prediction algorithms for the development of technology that can be used to handle caloric and protein deficit and monitor the energy balance. The next generation technology for enteral nutrition feeding can be used to create communication between ICU and post-ICU discharge units to understand the nutrition regime and predictive deficit. Hospital food left uneaten by patients can be analyzed to evaluate the energy, and protein and vitamins deficits. Similar approach could overcome the deficits in the post ICU period. The implementation of next generation technology-based tools in the critical stage could help to ensure that a patient's nutritional plan and goals are constantly measured, monitored, and achieved. In addition, wearable data could be integrated with Electronic Health Record (EHR) data, including data from sensors continuously measuring physical activity and glucose level. The growing fields of metabolomics and proteomics hold the potential to assess nutritional status, set appropriate adjustments of the nutrient mix, and monitor progress through various stages of illness. Therefore, the use of AI, prediction analytics, metabolomics and proteomics, and many next generation technologies in enteral medical nutrition for proper feeding routine is expected to create lucrative growth opportunities for the enteral medical nutrition market during the forecast period. 

Market Overview 

Asia Pacific is the fastest-growing regional market for enteral medical nutrition and is segmented into China, Japan, India, South Korea, Australia, and the Rest of APAC. The factors contributing to the growth of the enteral nutrition market in these countries are the rising prevalence of chronic diseases and the growing presence of market players across the country, conferring the highest manufacturing of enteral nutrition products. Furthermore, supportive government initiatives and research in the field of nutrition boost market growth. 

The countries such as Australia, India, and South Korea are estimated to serve various growth opportunities due to the rising development in the healthcare sector. In addition, the governments of these countries are increasing their efforts for enteral nutrition across the country. Also, the rise in the incidence of chronic diseases and the growing awareness regarding enteral nutrition will likely provide greater growth opportunities to the market players in the coming years. 

Asia Pacific Enteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million) 

Asia Pacific Enteral Medical Nutrition Market Segmentation 

The Asia Pacific enteral medical nutrition market is segmented into indication, nutrition type, form, product, distribution channel, age group and country. 

Based on indication, the Asia Pacific enteral medical nutrition market is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, and others. The respiratory disorders segment held the largest share in 2022. Based on nutrition type, the Asia Pacific enteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held the largest share of the market in 2022. Based on form, the Asia Pacific enteral medical nutrition market is segmented into powder, liquid, and semi-solid. The semi-solid segment held the largest share of the market in 2022. Based on product, the Asia Pacific enteral medical nutrition market is segmented into standard protein diet, high protein diet, fruit juice based oral nutrition, and others. The standard protein diet segment held the largest share of the market in 2022. Based on distribution channel, the Asia Pacific Enteral Medical Nutrition market is segmented into Hospital Pharmacies, Retail Stores and Other Pharmacies. The Hospital pharmacies segment held the largest share of the market in 2022. Based on Age Group, the Asia Pacific enteral medical nutrition market is segmented into child (till 18 years) and adults (above 18 years). The adult segment held the largest share of the market in 2022. Based on country, the market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the market in 2022. Abbott Laboratories; B. Braun Melsungen AG; DSM Nutritional Products AG; Fresenius Kabi AG; Global Health Products, Inc.; Hormel Foods Corporation; Meiji Holdings Co., Ltd.; Nestlé S.A.; Nutricia; and Smartfish AS are the leading companies operating in the enteral medical nutrition market in the region.

Asia Pacific Enteral Medical Nutrition Market Strategic Insights

Asia Pacific Enteral Medical Nutrition Market Segmentation Analysis

Asia Pacific Enteral Medical Nutrition Market Report Highlights

Asia Pacific Enteral Medical Nutrition Report Scope

Asia Pacific Enteral Medical Nutrition Market Country and Regional Insights